Effect of fecal microbiota transplantation on patients with sporadic amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled trial
Abstract Background Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder marked by the progressive loss of motor neurons. Recent insights into ALS pathogenesis underscore the pivotal role of the gut microbiome, prompting an investigation into the potential therapeutic impa...
Saved in:
Main Authors: | Renyi Feng, Qingyong Zhu, Ao Wang, Hanzhen Wang, Jiuqi Wang, Pei Chen, Rui Zhang, Dongxiao Liang, Junfang Teng, Mingming Ma, Xuebing Ding, Xuejing Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12916-024-03781-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pain in Amyotrophic Lateral Sclerosis Is Underrated
by: Soyoung Kwak, et al.
Published: (2024-12-01) -
Evaluation of Dysphagia in Amyotrophic Lateral Sclerosis
by: Xiao QIU, et al.
Published: (2017-02-01) -
Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
by: Yuhan Wu, et al.
Published: (2025-03-01) -
Prognostic Value of Systemic Inflammation, Nutritional Status and Sarcopenia in Patients With Amyotrophic Lateral Sclerosis
by: Yahui Zhu, et al.
Published: (2024-12-01)